ClinicalTrials.gg
Not yet recruitingNCT07836946PSE-GEMUpdated Sep 23, 2026

Pain Science Education and Graded Exposure for Chronic Low Back Pain

An interventional study of Pain Science Education Plus Graded Exposure and Usual Physical Therapy in Chronic Low-back Pain (cLBP), sponsored by University of Chile. Not yet recruiting. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-09-23.

Sponsored by University of Chile · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
82
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Chronic low back pain can affect daily activities and may be influenced by how people understand pain, their fear of movement, and their responses to stressful or uncertain physical activities. This clinical trial will evaluate whether a 6-week program combining pain science education with graded exposure to movement is more effective than usual physical therapy for adults with chronic low back pain.

Participants will be randomly assigned to one of two groups: pain science education combined with graded exposure to movement, or usual physical therapy. The study will assess changes in pain, disability, fear of movement, and pain-related thoughts. It will also examine physiological responses to stress and muscle activity while participants perform a lifting task.

The study aims to determine whether combining education about pain with gradual exposure to feared movements can improve clinical outcomes, physiological responses to stress, and motor performance in people with chronic low back pain.

02

Conditions studied

  • Chronic Low-back Pain (cLBP)

Browse trials for

03

In context

Low Back Pain

2,922 studies on the registry are indexed under Low Back Pain; 580 are open to participants now.

This study's planned enrollment of 82 is above the median of 60 across 2,364 interventional studies indexed under Low Back Pain.

Browse Low Back Pain studies →

Lead sponsor

University of Chile is the lead sponsor of 194 studies on the registry; 38 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Men and women aged 18 to 60 years.
  • Diagnosis of chronic low back pain, defined as low back pain occurring every day for at least 3 months or on at least half of the days during the previous 6 -months.
  • Willingness to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • >30 kg/m².
  • Inability to understand study instructions.
  • Neurological conditions affecting the central nervous system (e.g., stroke or spinal cord injury).
  • Pregnancy.
  • Currently receiving alternative therapies.
  • Previous participation in a pain education program.
  • History of trauma or orthopedic surgery within the previous 12 months.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
82 participants (estimated)

Study arms

  • Experimental
    Pain Science Education Plus Graded Exposure

    Participants will receive a 6-week program combining pain science education with graded exposure to movement. Pain science education will be delivered once weekly through a hybrid format, including group, individual online, and asynchronous sessions. Participants will also receive one individual, in-person graded exposure session per week for 6 weeks. Graded exposure will be individualized according to activities that participants fear or avoid, with progressive modification of load, speed, or range of motion.

    Behavioral: Pain Science Education Plus Graded Exposure

  • Active comparator
    Usual Physical Therapy

    Participants will receive usual physical therapy for 6 weeks. The intervention will include one group-based educational session on low back pain and one in-person physical therapy session per week for 6 weeks. Physical therapy will include stretching, thermotherapy, electrotherapy, and conventional core stabilization exercises. Participants will also be instructed to perform trunk stabilization exercises at home three days per week.

    Other: Usual Physical Therapy

Interventions

  • BehavioralPain Science Education Plus Graded Exposure

    Participants will receive six 30-minute pain science education sessions over 6 weeks, including two group sessions, two individual online sessions, and two asynchronous sessions. Education will address pain neurobiology, the relationship between pain and tissue damage, pain modulation, cognitive and emotional influences on pain, neuroplasticity, self-management, and the role of movement. Participants will also receive six weekly individual, in-person graded exposure sessions. Feared or avoided functional activities will be identified and hierarchically ordered, and participants will be gradually exposed to these activities. Progression will be individualized by modifying load, speed, or range of motion.

    Also known as: Pain Neuroscience Education Plus Graded Exposure

  • OtherUsual Physical Therapy

    Participants will receive one 30-minute group educational session addressing mechanical causes of low back pain, spinal anatomy, physiology and biomechanics, self-care and ergonomics, lifting techniques, and therapeutic exercise. Participants will also receive one in-person physical therapy session per week for 6 weeks, including stretching, thermotherapy, electrotherapy, and conventional core stabilization exercises (3-4 sets of 20-30 repetitions). Participants will be instructed to perform trunk stabilization exercises at home three days per week.

06

What researchers measure

Primary outcomes

  1. Pain Intensity

    Pain intensity will be assessed using a 100-mm Visual Analog Scale (VAS), ranging from 0 mm ("no pain") to 100 mm ("worst pain imaginable"). Higher scores indicate greater pain intensity.

    Time frame: Baseline and immediately after the 6-week intervention

  2. Low Back Pain-Related Disability

    Disability will be assessed using the validated Spanish version of the Roland-Morris Disability Questionnaire (RMDQ). The questionnaire consists of 24 items scored as 0 or 1, resulting in a total score ranging from 0 to 24. Higher scores indicate greater low back pain-related disability.

    Time frame: Baseline and immediately after the 6-week intervention

Secondary outcomes

  1. Heart Rate Variability

    Heart rate variability (HRV) will be assessed using time- and frequency-domain measures, including high-frequency (HF) power, low-frequency (LF) power, and the root mean square of successive differences (RMSSD). HRV will be assessed at rest and during anticipation of the lifting task.

    Time frame: Baseline and immediately after the 6-week intervention

  2. Skin Conductance

    Skin conductance will be assessed using the MED-STORM PAIN MONITOR. The number of fluctuations in skin conductance per second (NFSC) will be recorded using electrodes placed on the palms of the hands. Skin conductance will be assessed at rest and during anticipation of the lifting task, with higher NFSC values indicating greater sympathetic reactivity.

    Time frame: Baseline and immediately after the 6-week intervention

  3. Trunk Muscle Co-contraction During the Lifting Task

    Surface electromyography (sEMG) will be recorded from the external oblique, rectus abdominis, erector spinae, and multifidus during the lifting task. Muscle co-contraction will be calculated from the area of overlap between paired muscle activation profiles, resulting in values ranging from 0 to 1, where 1 represents complete overlap.

    Time frame: Baseline and immediately after the 6-week intervention

  4. Kinesiophobia

    Kinesiophobia will be assessed using the Spanish version of the 11-item Tampa Scale for Kinesiophobia (TSK-11). Total scores range from 11 to 44, with higher scores indicating greater kinesiophobia.

    Time frame: Baseline and immediately after the 6-week intervention

  5. Task-Specific Fear

    Fear related specifically to the lifting task will be assessed using an 11-point Numerical Rating Scale ranging from 0 to 10, with higher scores indicating greater task-specific fear.

    Time frame: Baseline and immediately after the 6-week intervention

  6. Pain Catastrophizing

    Pain catastrophizing will be assessed using the 13-item Pain Catastrophizing Scale (PCS). Each item is scored from 0 to 4, resulting in a total score ranging from 0 to 52. Higher scores indicate greater pain catastrophizing

    Time frame: Baseline and immediately after the 6-week intervention

  7. Intolerance of Uncertainty

    Intolerance of uncertainty will be assessed using the 27-item Intolerance of Uncertainty Scale. Each item is rated on a 5-point scale from 1 ("not at all characteristic of me") to 5 ("entirely characteristic of me"), with higher scores indicating greater intolerance of uncertainty.

    Time frame: Baseline and immediately after the 6-week intervention

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Yes — Deidentified individual participant data underlying the results reported in the primary publication may be made available to qualified researchers upon reasonable request to the corresponding author.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07836946
Collaborators
Agencia Nacional de Investigación y Desarrollo
Responsible party
RODRIGO NUNEZ (Principal Investigator, University of Chile) — Principal investigator
First posted
Sep 23, 2026
Start date
Nov 2, 2026 (estimated)
Primary completion
Mar 31, 2028 (estimated)
Completion
Mar 31, 2028 (estimated)
Last update
Sep 23, 2026

Study contacts

Rodrigo Núñez-Cortés, PhD
Contact
r_nunez@uchile.cl
928777254

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion